Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Human Immunodeficiency Virus (HIV)
- Sponsor
- Hunter College of City University of New York
- Enrollment
- 438
- Locations
- 1
- Primary Endpoint
- PrEP Uptake
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
This study identifies social and behavioral factors likely to influence PrEP acceptability and adherence among men who have sex with men (MSM), and collaborates with a community health center to evaluate a two-stage intervention to improve PrEP decision-making, as well as persistence and adherence for those who chose to take PrEP.
Detailed Description
Pre-exposure prophylaxis (PrEP) refers to daily or intermittent oral administration of antiretroviral drugs designed to protect high-risk HIV-negative individuals from infection. In order for PrEP to become an effective prevention tool, three critical factors must be addressed: a) acceptability, i.e., individuals who would benefit from PrEP must know about it and be willing to take it; b) adherence, i.e., individuals who choose to PrEP as a prevention strategy must take the pills as prescribed; and c) implementation, i.e., processes and protocols must be developed to allow for the integration of PrEP delivery and programs into real world settings in a way that is feasible, scalable, and realistic. This project has three specific aims: 1) Identifying social and behavioral factors that are likely to influence PrEP implementation, acceptance, and use/adherence by men who have sex with men (MSM) in NYC, including factors at individual-, community-, and organizational-levels; 2) Examining social and behavioral factors associated with disparities in access to prevention and care services among MSM in NYC that might directly impact PrEP implementation programs and policies; and 3) Evaluating an intervention in which PrEP is introduced, provided, and supported as part of a prevention package delivered in an community health center. The project has the potential to exert a sustained and powerful influence not only on the effectiveness of PrEP interventions for MSM, but also on dissemination and scalability of a targeted intervention within community-based settings and in a manner that reduces disparities in access and maximizes cultural competence and acceptability.
Investigators
Sarit Golub
Associate Professor
Hunter College of City University of New York
Eligibility Criteria
Inclusion Criteria
- •Registered patient receiving medical or health services at Callen-Lorde Community Health Center
- •Male sex (at birth) and reported sex with men or transwomen
- •At least 18 years of age
- •HIV-negative
- •At risk for HIV acquisition
Exclusion Criteria
- •Past history of PrEP use or currently taking PrEP
Outcomes
Primary Outcomes
PrEP Uptake
Time Frame: BL through 3-months
Whether or not the patient decides to take PrEP
Sexual Risk Behavior
Time Frame: BL through 12-months
Measured through STI testing and self-report.
PrEP Persistence
Time Frame: BL through 12-months
Whether or not patients who decide to take PrEP persist with the medication for the duration of the study.
PrEP Adherence
Time Frame: BL through 12 months
Biological measure of medication adherence using dried blood spots, and self-report measure of adherence using VAS.